Exposure to radiation harms the body by damaging rapidly dividing cells, including those in the intestine, allowing potentially pathogenic bacteria to escape into the bloodstream and cause infection. Antibiotics, such as fluoroquinolone, are therefore frequently used as a treatment for radiation exposure. Radiation also depletes a protein called bactericidal/permeability-increasing protein (BPI), which normally acts to neutralize endotoxin (found in intestinal bacteria) in the blood. A research team led by Eva C. Guinan (Dana-Farber Cancer Institute, Boston, MA) recently showed that supplying BPI along with fluoroquinolone mitigated toxicity of radiation exposure in mice.
In the study, mice were exposed to doses of radiation that usually prove lethal, and indeed 95% of the control mice died within 30 days after exposure. In comparison, in mice treated with fluoroquinolone, mortality at 30 days was roughly 60%. Furthermore, in mice given fluoroquinolone and BPI, mortality dropped to about 20% (Sci. Transl. Med. doi:10.126/scitranslmed.3003126; published online 23 November 2011).
This is a preview of subscription content, access via your institution